Dandekar Atul

Track

Insider profile

Dandekar Atul's trades of Maze Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
27.58
Quantity 7,500 -22.2%
Value US$206,824
Transaction date
Planned sale
Price
27.31
Quantity 7,100 -21.0%
Value US$193,875
Transaction date
Planned sale
Price
28.02
Quantity 7,500 -22.2%
Value US$210,150
Transaction date
Planned sale
Price
26.34
Quantity 7,500 -23.2%
Value US$197,554
Transaction date
Planned sale
Price
25.37
Quantity 7,500 -41.7%
Value US$190,299
Transaction date
Planned sale
Price
29.26
Quantity 6,710 -37.3%
Value US$196,305
Transaction date
Planned sale
Price
45.72
Quantity 3,761 -26.4%
Value US$171,967
Transaction date
Planned sale
Price
45.13
Quantity 3,739 -20.8%
Value US$168,756
Transaction date
Planned sale
Price
45.01
Quantity 2,800 -21.0%
Value US$126,022
Transaction date
Planned sale
Price
44.04
Quantity 3,500 -20.8%
Value US$154,147
Transaction date
Planned sale
Price
41.13
Quantity 6,035 -36.5%
Value US$248,211
Transaction date
Planned sale
Price
40.51
Quantity 66,365 -80.1%
Value US$2,688,552
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-04 2026-09-03
S Sale
64,090 -1.2%
481.71
US$3,455,755 		64,090 -1.2% 481.71 US$3,455,755
2026-09-04 2026-09-03
S Sale
40,645 +30.6%
302.06
US$4,844,899 		40,645 +30.6% 302.06 US$4,844,899
2026-09-04 2026-09-02
S Sale
88,503 -42.3%
236.98
US$4,828,705 		88,503 -42.3% 236.98 US$4,828,705
2026-09-04 2026-09-02
S Sale
2,800 -7.2%
26.38
US$73,853 		2,800 -7.2% 26.38 US$73,853
2026-09-02 2026-09-02
PrS Proposed sale
6,679
26.53
US$177,200 		6,679 26.53 US$177,200
2026-08-31 2026-08-28
PlS Planned sale
7,500 -22.2%
27.58
US$206,824 		7,500 -22.2% 27.58 US$206,824
2026-07-31 2026-07-29
PlS Planned sale
400 -1.5%
27.89
US$11,156 		400 -1.5% 27.89 US$11,156
2026-07-31 2026-07-29
PlS Planned sale
7,100 -21.0%
27.31
US$193,875 		7,100 -21.0% 27.31 US$193,875
2026-07-29 2026-07-29
PrS Proposed sale
22,500
27.88
US$627,300 		22,500 27.88 US$627,300
2026-07-01 2026-06-29
PlS Planned sale
7,500 -22.2%
28.02
US$210,150 		7,500 -22.2% 28.02 US$210,150
2026-06-02 2026-05-29
PlS Planned sale
7,500 -23.2%
26.34
US$197,554 		7,500 -23.2% 26.34 US$197,554
2026-05-01 2026-04-29
PlS Planned sale
7,500 -41.7%
25.37
US$190,299 		7,500 -41.7% 25.37 US$190,299
2026-04-01 2026-03-30
PlS Planned sale
790 -7.0%
30.02
US$23,714 		790 -7.0% 30.02 US$23,714
2026-04-01 2026-03-30
PlS Planned sale
6,710 -37.3%
29.26
US$196,305 		6,710 -37.3% 29.26 US$196,305
2026-03-30 2026-03-30
PrS Proposed sale
30,000
30.38
US$911,400 		30,000 30.38 US$911,400
2026-03-03 2026-02-27
PlS Planned sale
3,761 -26.4%
45.72
US$171,967 		3,761 -26.4% 45.72 US$171,967
2026-03-03 2026-02-27
PlS Planned sale
3,739 -20.8%
45.13
US$168,756 		3,739 -20.8% 45.13 US$168,756
2026-02-02 2026-01-29
PlS Planned sale
2,800 -21.0%
45.01
US$126,022 		2,800 -21.0% 45.01 US$126,022
2026-02-02 2026-01-29
PlS Planned sale
3,500 -20.8%
44.04
US$154,147 		3,500 -20.8% 44.04 US$154,147
2026-02-02 2026-01-29
PlS Planned sale
1,200 -6.7%
43.18
US$51,821 		1,200 -6.7% 43.18 US$51,821
2025-12-31 2025-12-30
PlS Planned sale
100 -0.9%
40.36
US$4,036 		100 -0.9% 40.36 US$4,036
2025-12-31 2025-12-29
PlS Planned sale
6,035 -36.5%
41.13
US$248,211 		6,035 -36.5% 41.13 US$248,211
2025-12-31 2025-12-29
PlS Planned sale
66,365 -80.1%
40.51
US$2,688,552 		66,365 -80.1% 40.51 US$2,688,552
2025-12-29 2025-12-29
PrS Proposed sale
87,500
42.10
US$3,683,750 		87,500 42.10 US$3,683,750